Targeted for: Corporate Purchasing Managers, Technical Directors, Operations Managers in the United States who demand high‑purity API, on‑time delivery, and full compliance with FDA, GMP, and ISO standards.
Why settle for high price, low quality, or slow shipping? Our Powerful Factory combines OEM/ODM design flexibility with a high‑speed logistics network to give you the competitive edge you need.
Get Free Quote in 24 h1. Excessive Cost Structures – Many suppliers charge a premium for Degarelix intermediate, inflating your R&D budget by up to 30 %.
2. Inconsistent Purity & Impurity Profiles – A single‑digit impurity variation can jeopardize clinical trial approvals and trigger regulatory holds.
3. Long Lead Times – Overseas shipments often exceed 45 days, delaying formulation work and market entry.
4. Unclear Regulatory Documentation – Missing Certificates of Analysis (CoA), GMP audit reports, or FDA import clearance documents cause compliance bottlenecks.
5. Limited Customization Options – Your formulation may require specific particle size, salt form, or bulk packaging; many vendors cannot accommodate these requests.
Data Point: A 2025 industry survey of 312 pharmaceutical manufacturers reported that 68 % cited “supplier lead time” as the top barrier to on‑schedule product launch.
Discover the Solution →| Parameter | Specification |
|---|---|
| Chemical Name | Degarelix Intermediate |
| CAS No. | 866044‑63‑5 |
| Molecular Formula | C₁₁₁H₁₈₁N₃₃O₁₈ |
| Molecular Weight | 2070.43 g·mol⁻¹ |
| Purity (HPLC) | ≥ 99.9 % (≤ 0.1 % impurities) |
| Appearance | White to off‑white powder |
| Solubility | Soluble in DMSO, DMF; sparingly soluble in water |
| Stability | Stable 24 months at 25 °C, 60 % RH |
| Certificates | GMP, ISO 9001, FDA, CE, RoHS |
Case 1 – Oncology Clinical Trial (USA)
A leading biotech company needed 2 kg of Degarelix intermediate for a Phase II prostate‑cancer trial. Our 48‑hour dispatch and 8‑day air freight resulted in a 30 % faster start‑up compared with their previous supplier. The batch passed all FDA‑CFR‑610 inspections on the first attempt.
Case 2 – Contract Manufacturing Organization (CMO) in Canada
The CMO required a custom salt form (Degarelix acetate) and a particle‑size distribution of 20‑40 µm. Our in‑house formulation team delivered a pilot‑scale batch within 3 weeks, enabling the CMO to meet a tight client deadline and saving USD 45,000 in re‑processing costs.
Standard orders (≥ 100 g) are processed within **48 hours** and shipped via air freight to the U.S. in **7‑10 days**. Express courier service is available for urgent batches (<10 g) with a **3‑day** delivery window.
Yes. Our R&D lab offers **OEM/ODM** services, including salt conversion (e.g., acetate, hydrochloride) and micronization to a target range of **10‑50 µm**. Minimum custom batch size is 5 g.
Every shipment includes a **Certificate of Analysis (CoA)**, **GMP audit report**, **Material Safety Data Sheet (MSDS)**, and **Import/Export declaration** compliant with FDA and U.S. Customs regulations.
Our production line utilizes **in‑process HPLC monitoring**, **real‑time NIR spectroscopy**, and a **statistical process control (SPC)** system. Each batch undergoes full analytical validation before release.

We accept **T/T**, **Letter of Credit (L/C)**, **PayPal**, and **U.S. corporate credit cards**. Standard terms are **30 % T/T in advance, 70 % before shipment**; L/C at sight is also available for larger contracts.
Yes. We provide **free 5 g samples** (subject to NDA) for qualified corporate buyers. Samples are shipped via express courier within **2 business days** after request approval.
Act now and enjoy a **risk‑free trial**: we’ll ship a **5 g free sample** plus a **money‑back guarantee** if the material does not meet the quoted purity.
Or fill the quick form below – we’ll respond within **2 hours**.
Dr. Laura Martinez, Senior Scientist – Gilead Sciences
“The Degarelix intermediate arrived on schedule, and the analytical data matched the CoA perfectly. This reliability let us keep our clinical trial on track and avoid costly delays.”
Michael O’Connor, Procurement Lead – AstraZeneca
“Their OEM service saved us a full month in formulation development. The custom particle size was spot‑on, and the price was **25 % lower** than our previous supplier.”
Sarah Lee, Operations Manager – Novartis
“Fast, transparent, and fully compliant. The CoA, GMP audit report, and MSDS were all in order, making our FDA filing a breeze.”
Trusted By Global Leaders
Regulatory & Quality Certifications